查詢結果分析
相關文獻
- Combination of Pembrolizumab and Lenvatinib Is a Potential Treatment Option for Heavily Pretreated Recurrent and Metastatic Head and Neck Cancer
- 黑色素瘤治療新藥--Pembrolizumab
- 疑似Pembrolizumab引起肺炎
- Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Related to Immune Checkpoint Inhibitors: Two Cases and Literature Review
- Pembrolizumab和Ipilimumab用在卵巢癌治療的檢視
- Blurred Vision as the Initial Presentation of Choroidal Metastasis of Lung Cancer in a 40-year-old Man--A Case Report
- Pembrolizumab可用於三陰性乳癌?
- Lenvatinib治療轉移性肝細胞癌
頁籤選單縮合
題 名 | Combination of Pembrolizumab and Lenvatinib Is a Potential Treatment Option for Heavily Pretreated Recurrent and Metastatic Head and Neck Cancer |
---|---|
作 者 | Chen, Tien-hua; Chang, Peter Mu-hsin; Yang, Muh-hwa; | 書刊名 | Journal of the Chinese Medical Association |
卷 期 | 84:4 2021.04[民110.04] |
頁 次 | 頁361-367 |
分類號 | 418.29 |
關鍵詞 | Head and neck cancer; Lenvatinib; Pembrolizumab; Programmed cell death 1; |
語 文 | 英文(English) |